Skip to content

Kinetics of extracellular vesicles in hemodialysis

Kinetics of extracellular vesicles in hemodialysis - EV kinetics study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53277
Enrollment
6
Registered
2023-09-18
Start date
2023-11-07
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tissue injury and bio-incompatibility in hemodialysis

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age >= 18 years - Stable clinical situation: free of infection, no recent admission - Treatment with HD >3 months - Haemoglobin level >= 6,2 mmol/L - Residual diuresis

Exclusion criteria

Exclusion criteria: - Active infection, malignancy, auto-immune disease, or treatment with immunosuppressive medication. - Allergy to polysulfone dialyzers - Life expectancy

Design outcomes

Primary

MeasureTime frame
Concentration of EVs in peripheral blood (i. e. CD45, CD61, CD62e, CD62p, CD235, CD62e, CD144, Connexin-43)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026